Inventor · Potomac, MD, US

Peter Kiener

22Patents
8h-index
29Co-inventors
75Inventor score

Filing activity: May 17, 1989 → May 4, 2018

Most-cited inventions

PatentTitleAreaCited byStatus
US5122368A Anthracycline conjugates having a novel linker and methods for their production Human Necessities 305 Expired
US5977318A CTLA4 receptor and uses thereof Emerging Cross-Sectional Technologies 151 Expired
US5851795A Soluble CTLA4 molecules and uses thereof Emerging Cross-Sectional Technologies 99 Expired
US5968510A CTLA4 receptor and uses thereof Emerging Cross-Sectional Technologies 88 Expired
US5885579A CTLA4 receptor and uses thereof Emerging Cross-Sectional Technologies 64 Expired
US7658921B2 Molecules with extended half-lives, compositions and uses thereof Chemistry; Metallurgy 56 Active
US8323653B2 Humanized anti-CD19 antibodies and their use in treatment of oncology, transplantation and autoimmune disease Emerging Cross-Sectional Technologies 22 Active
US7585504B2 High affinity antibodies against HMGB1 and methods of use thereof Emerging Cross-Sectional Technologies 16 Active
US10150800B2 EGFR-binding modular recognition domains Emerging Cross-Sectional Technologies 7 Active
US8137670B2 Method of identifying membrane IgE specific antibodies and use thereof for targeting IgE producing precursor cells Emerging Cross-Sectional Technologies 7 Active
US9676833B2 Ang-2-binding modular recognition domain complexes and pharmaceutical compositions thereof Chemistry; Metallurgy 6 Active
US7964706B2 High affinity antibodies against HMGB1 and methods of use thereof Chemistry; Metallurgy 6 Active
US8883992B2 Humanized anti-CD19 antibodies Emerging Cross-Sectional Technologies 3 Active
US8129130B2 High affinity antibodies against HMGB1 and methods of use thereof Chemistry; Metallurgy 3 Active
US8153131B2 High affinity antibodies against HMGB1 and methods of use thereof Emerging Cross-Sectional Technologies 3 Active
US6455683B1 DNA molecules encoding human CLAX proteins and their soluble fusion proteins Chemistry; Metallurgy 3 Expired
US9896505B2 Humanized anti-CD19 antibodies and their use in treatment of oncology, transplantation and autoimmune disease Emerging Cross-Sectional Technologies 2 Active
US9988459B2 Anti-IFNAR1 antibodies with reduced Fc ligand affinity Chemistry; Metallurgy 2 Active
US8404236B2 Method of identifying membrane Ig specific antibodies and use thereof for targeting immunoglobulin-producing precursor cells Emerging Cross-Sectional Technologies 1 Active
US10301390B2 Anti-IFNAR1 antibodies with reduced Fc ligand affinity Chemistry; Metallurgy 1 Active
US10087222B2 Polynucleotides encoding angiopoietin-2 (ang-2) binding polypeptides Chemistry; Metallurgy 0 Active
US10526381B2 Multivalent and monovalent multispecific complexes and their uses Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.